Quick-Med Technologies, Inc. is pleased to announce that a team of
scientists from Quick-Med received the Blue Ribbon Award at the
Symposium on Advanced Wound Care and Wound Healing Society’s
21st Annual Meeting for the outstanding abstract entitled: "Persistent
Skin Sanitizer (NimbuDerm™) with Sustained
Microbicidal Properties.” The abstract
was sponsored by Quick-Med Technologies and the University of Florida at
Gainesville.
The Wound Healing Society offers the Blue Ribbon Industrial Research
& Development Award to recognize the best product-oriented
research performed by research and development scientists within the
corporate world. This year, a total of 11 blue ribbons were awarded
including 2 to teams from Quick-Med Technologies. Other participants at
the SAWC/WHS event were prominent companies such as Johnson & Johnson
Wound Management, 3M Healthcare, Kinetic Concepts, Inc., and
Healthpoint, Ltd., as well as leading educational institutions such as
the Harvard Medical School, Stanford University, and the University of
Pennsylvania School of Medicine.
"We are honored to receive this important
recognition from such a prestigious organization as the Wound Healing
Society,” said J. Ladd Greeno, CEO of
Quick-Med Technologies. "NimbuDerm technology
represents an important breakthrough that has the potential to
dramatically improve hand hygiene by combining the power of an instant
sanitizer with long-lasting personal protection.”
This project team is lead by David Moore1 and
includes William Toreki1, Roy Carr1,
Gregory Schultz1,2, Christopher Batich1,2,
Albina Mikhaylova1, Jillian Vella1,
and Gerald Olderman1. (1Quick-Med
Technologies, Inc.; 2University of Florida)
Human use tests show that NimbuDerm is both instant and provides a high
level of continuing antimicrobial protection for 6 hours after
application without wearing off or losing its effectiveness. Poor hand
hygiene is considered to be a major contributor to the spread of
infectious diseases and the increase of potentially deadly
methicillin-resistant Staphylococcus aureus, or MRSA infections.
NimbuDerm, an extension of Quick-Med’s NIMBUS®
technology, opens up new application vistas as a result of its liquid
form, unique properties, and formulation flexibility.
The poster in its entirety can be accessed by clicking
here. About the Wound Healing Society
The Wound Healing Society is a non-profit organization composed of
clinical and basic scientists. The Society provides a forum for
interaction among scientists, physicians, licensed practitioners,
industrial representatives and government agencies. Founded in 1990, the
Society is recognized among professionals and government agencies as the
leading scientific organization focused in this area of wound healing.
The Society publishes the leading journal in this area, Wound Repair and
Regeneration.
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is
developing innovative technologies for the healthcare and consumer
markets. For more information, see: www.quickmedtech.com.
© 2008 Quick-Med Technologies, Inc. All
rights reserved. NIMBUS® is a registered
trademark and NimbuDerm™ is a trademark of
Quick-Med Technologies, Inc.
Forward-looking statements (statements which are not historical
facts) in this release are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. For this
purpose, any statements contained in this release that are not
statements of historical fact may be deemed to be forward-looking
statements. Without limiting the generality of the foregoing, words such
as "may", "will", "to,” "expect,” "plan,” "believe,” "anticipate,” "intend,” "could,” "would,” "estimate,”
and/or "continue”
or the negative or other variations thereof or comparable terminology is
intended to identify forward-looking statements involve risks and
uncertainties, including those risks that are discussed in the Company’s
filings with the Securities and Exchange Commission ("SEC”),
which may be accessed at the SEC’s
Edgar System at www.sec.gov.